Puhlmann Markus
SEC CIK 1965071 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | Chief Medical Off | 1.38M | $328.2K | — | 2 | 2023-12-15 | 2024-01-24 |
Most active insiders at CATX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lantheus Alpha Therapy, LLC | 10% | — | $1.27M |
| 2 | Lantheus Holdings, Inc. | 10% | — | $357.2K |
| 3 | Hunt Jonathan Robert | CAO | $22.3K | — |
| 4 | Williamson Robert F III | Dir | $19.9K | — |
Puhlmann Markus made no open-market trades at CATX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-26 | 2024-01-24 | CATX | Perspective Therapeutics, Inc. | Puhlmann Markus | Chief Medical Off | P - Purchase | $0.5 | +280.0K | 1.38M | +26% | +$140.0K | |
| M | 2023-12-19 | 2023-12-15+ | CATX | Perspective Therapeutics, Inc. | Puhlmann Markus | Chief Medical Off | P - Purchase | $0.316 | +595.4K | 635.0K | +1,504% | +$188.2K |
Purchase Sale Sale after option exercise All abbreviations